within Pharmacolibrary.Drugs.ATC.H;

model H05BA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.71,
    Cl             = 0.013333333333333334,
    adminDuration  = 600,
    adminMass      = 0.0001,
    adminCount     = 1,
    Vd             = 0.00015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Calcitonin (salmon synthetic) is a synthetic polypeptide hormone analog of salmon calcitonin, used to inhibit osteoclastic bone resorption. Clinically, it is approved for the treatment of postmenopausal osteoporosis, Paget's disease of bone, and hypercalcemia. It is used parenterally or as an intranasal spray, with decreasing use today due to newer osteoporosis therapies, but it still holds approval for certain clinical indications.</p><h4>Pharmacokinetics</h4><p>Reported in healthy adult volunteers after subcutaneous administration.</p><h4>References</h4><ol><li><p>Zhu, Q, et al., &amp; Qi, J (2021). Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. <i>Acta pharmaceutica Sinica. B</i> 11(8) 2416–2448. DOI:<a href=&quot;https://doi.org/10.1016/j.apsb.2021.04.001&quot;>10.1016/j.apsb.2021.04.001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34522593/&quot;>https://pubmed.ncbi.nlm.nih.gov/34522593</a></p></li><li><p>Chaturvedula, A, et al., &amp; Banga, AK (2005). In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. <i>International journal of pharmaceutics</i> 297(1-2) 190–196. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2005.03.019&quot;>10.1016/j.ijpharm.2005.03.019</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15907605/&quot;>https://pubmed.ncbi.nlm.nih.gov/15907605</a></p></li><li><p>Wang, Z, et al., &amp; Zhang, Y (2020). Injectable Carrier for Zero-Order Release of Salmon Calcitonin. <i>ACS biomaterials science &amp; engineering</i> 6(1) 485–493. DOI:<a href=&quot;https://doi.org/10.1021/acsbiomaterials.9b01680&quot;>10.1021/acsbiomaterials.9b01680</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33463212/&quot;>https://pubmed.ncbi.nlm.nih.gov/33463212</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H05BA01;
